Switzerland is known for providing bespoke pharmaceutical solutions through its access to and funding for intensive research and development of low volume speciality chemicals. Switzerland has seen many success stories and inventions in the pharmaceutical industries. Roche is credited with inventing Invirase, the world’s first HIV protease inhibitor drug in 1995 and later, co-created Funzeon, which stops the HIV virus from entering human cells. In addition, Novartis has been widely recognised for their work on cancer treatment through their aromatase blocker letrozole (Femara) which is used in the treatment of early-stage breast cancer.

Turning ideas into innovation, research and development (R&D) is the lifeblood of the life sciences industry. In an increasingly competitive environment, a company’s survival is almost wholly dependent on the discovery and development of new products, including medicines, vaccines and medical devices. Research and development is a serious investment in time and money – on average, large multinational drug companies spend 17% of their revenues of R&D. The average cost to research and develop each successful drug is estimated to be $2.6 billion, while it takes approximately ten years to bring a new drug to market.

Technological advancements have reduced the cost of research and development – helping to accelerate investment in life sciences – while also creating new opportunities for product innovations as the Fourth Industrial revolution blurs the boundaries between the biological, physical and digital worlds. According to a report by KPMG, the cost of drug R&D will drop by 2030, leading to numerous benefits for the both the industry and consumer in terms of cost savings.

Interpharma is the leading representational body for research-based pharmaceutical companies in Switzerland and provides a wealth of information to its network through regular market updates and reports. At 5.5 billion francs, the pharmaceutical industry accounted for around 35% of all in-house R&D spending in Switzerland, which was thus around three times as high as the amount spent in the engineering and metal industry. Globally, R&D spending in medical device is anticipated to grow by 4.5% to hit $39 billion by 2024.

Our Zurich based consultants are specialists in their markets, recruiting top talent for the R&D jobs market throughout Switzerland and Europe.

Principal Scientist Bioanalytical
Negotiable, Boston

Principal Scientist - Bioanalytical Location: Boston, MA Working situation: Hybrid Model Level: P...

Apply now
Senior Manager Analytical Development
Negotiable, Princeton

Senior Manager, Analytical Development Location: Princeton, New Jersey Working Situation: Hybrid ...

Apply now
Scientist- Assays-Regents
Negotiable, Rockville

Assay Reagents Scientist Location: Rockville, MD Working Situation: On-site Our client is looking...

Apply now
Research Associate
Up to US$45 per hour, San Francisco

**Onsite in Redwood City, CA** Job opportunity with a top biopharmaceutical company that is looki...

Apply now
Sr. Analytical Development Scientist - Biologics
US$130000 - US$140000 per annum, Austin

Sr. Scientist, Analytical Development Company Summary: An Austin, TX based biotech is currently s...

Apply now
BIOLOGIST (ELISA & Mammalian Cell Culture experience)
US$38.50 - US$45 per hour, South Plainfield

New Jersey-based BioPharma company is actively hiring for multiple Biologists to assist early-sta...

Apply now
Sr Research Associate
US$40 - US$45 per hour, Waltham

The Sr research associate will be working to contribute to the early discover of early biological...

Apply now
Lab Manager
US$45 - US$50 per hour, San Francisco

**Onsite Role, Foster City, CA** Job opportunity with a top biopharmaceutical company that is loo...

Apply now
Up to US$40 per hour, New Jersey

**Onsite Role, South Plainfield, NJ** Job opportunity with a top biopharmaceutical company that i...

Apply now